Search research articles
Contact Us
Filters
Showing results (271-280 of 336) with videos related to
Page
of 34
Sort By:
Journal of Personalized Medicine
|
May 28, 2022
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
Andrea Vereczkei, Csaba Barta, Anna Magi, et al.
Journal of Addiction Psychiatry
|
February 14, 2025
Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases
Kenneth Blum, Thomas Mclaughlin, Kai Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
December 2, 2024
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs
Edward Justin Modestino, Abdalla Bowirrat, David Baron, et al.
Journal of Personalized Medicine
|
December 23, 2022
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, et al.
Journal of Personalized Medicine
|
October 27, 2022
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Kenneth Blum, Catherine A Dennen, Igor Elman, et al.
Journal of Psychiatric Research
|
June 20, 2025
Long-COVID-19 and Cognition: Persistent attention deficits after hospital discharge
Aureo do Carmo Filho, Max Kopti Fakoury, Guilherme Janeiro Schmidt, et al.
Advances in Therapy
|
September 11, 2008
LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome
Kenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
Journal of Personalized Medicine
|
August 29, 2024
Assessing the Impact of IL-6 and Serotonin on Pain and Symptomatology in Fibromyalgia: An Exploratory Clinical Study
Felipe Altino Loçasso, Hélcio Alvarenga Filho, Regina Maria Papais Alvarenga, et al.
Current Pharmaceutical Biotechnology
|
December 11, 2019
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair
Lyle Fried, Edward J Modestino, David Siwicki, et al.
Molecular Neurobiology
|
February 29, 2012
Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?
Abdalla Bowirrat, Thomas J H Chen, Marlene Oscar-Berman, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 336) with videos related to
Sort By:
Page
of 34
Journal of Personalized Medicine
|
May 28, 2022
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
Andrea Vereczkei, Csaba Barta, Anna Magi, et al.
Journal of Addiction Psychiatry
|
February 14, 2025
Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases
Kenneth Blum, Thomas Mclaughlin, Kai Uwe Lewandrowski, et al.
Journal of Addiction Psychiatry
|
December 2, 2024
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs
Edward Justin Modestino, Abdalla Bowirrat, David Baron, et al.
Journal of Personalized Medicine
|
December 23, 2022
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, et al.
Journal of Personalized Medicine
|
October 27, 2022
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Kenneth Blum, Catherine A Dennen, Igor Elman, et al.
Journal of Psychiatric Research
|
June 20, 2025
Long-COVID-19 and Cognition: Persistent attention deficits after hospital discharge
Aureo do Carmo Filho, Max Kopti Fakoury, Guilherme Janeiro Schmidt, et al.
Advances in Therapy
|
September 11, 2008
LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome
Kenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
Journal of Personalized Medicine
|
August 29, 2024
Assessing the Impact of IL-6 and Serotonin on Pain and Symptomatology in Fibromyalgia: An Exploratory Clinical Study
Felipe Altino Loçasso, Hélcio Alvarenga Filho, Regina Maria Papais Alvarenga, et al.
Current Pharmaceutical Biotechnology
|
December 11, 2019
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair
Lyle Fried, Edward J Modestino, David Siwicki, et al.
Molecular Neurobiology
|
February 29, 2012
Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?
Abdalla Bowirrat, Thomas J H Chen, Marlene Oscar-Berman, et al.
Page
of 34